World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
113
Citations
42793
World Ranking
437
National Ranking
268

Medicine

D-Index
113
Citations
42871
World Ranking
4996
National Ranking
2710

James E. Crowe publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James E. Crowe sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 612 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

James E. Crowe D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James E. Crowe sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 113 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2009 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 2005 - Oswald Avery Award, Infectious Diseases Society of America

Overview

James E. Crowe is affiliated with Vanderbilt University Medical Center in the United States. Their primary field of study is Medicine, with a significant focus on Infectious Diseases. Subfields of research include Epidemiology, Molecular Biology, Public Health, Environmental and Occupational Health, and Radiology, Nuclear Medicine and Imaging.

The scientist's research extensively covers topics related to viral infections and immunology. Major areas of work consist of:

  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Vectors
  • Viral Infections and Outbreaks Research
  • Mosquito-borne Diseases and Control
  • Monoclonal and Polyclonal Antibodies Research
  • Viral Gastroenteritis Research and Epidemiology
  • Respiratory Viral Infections Research

Frequent coauthors collaborating with James E. Crowe include:

  • Robert H. Carnahan
  • Michael Diamond
  • Pavlo Gilchuk
  • Naveenchandra Suryadevara
  • Rachel E. Sutton

The researcher has published many papers in prestigious scientific journals and venues, with some of the main publication platforms being bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Nature Communications, Cell Reports, and Cell.

Significant recent papers authored or co-authored by James E. Crowe include:

  • Potently neutralizing and protective human antibodies against SARS-CoV-2, 2020, Nature
  • Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition, 2020, Cell Host & Microbe
  • Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies, 2021, Nature Medicine
  • Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19, 2020, Nature Immunology
  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies, 2022, Nature Medicine

James E. Crowe has received professional recognition within the scientific community, including election as a Fellow of the American Association for the Advancement of Science (AAAS) in 2009 and the Oswald Avery Award from the Infectious Diseases Society of America in 2005.

Best Publications

  • Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

    John V. Williams;Paul A. Harris;Sharon J. Tollefson;Lisa L. Halburnt-Rush

  • Potently neutralizing and protective human antibodies against SARS-CoV-2.

    Seth J. Zost;Pavlo Gilchuk;James Brett Case;Elad Binshtein

  • Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition.

    Allison J. Greaney;Allison J. Greaney;Tyler N. Starr;Pavlo Gilchuk;Seth J. Zost

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.

    Rita E. Chen;Xianwen Zhang;James Brett Case;Emma S. Winkler

  • Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

    Rui Xu;Damian C. Ekiert;Jens C. Krause;Rong Hai

  • Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.

    Matthew C. Woodruff;Richard P. Ramonell;Doan C. Nguyen;Kevin S. Cashman

  • Proof of principle for epitope-focused vaccine design

    Bruno Emanuel F. Sousa Correia;John T. Bates;Rebecca J. Loomis;Gretchen Baneyx

  • Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

    Xiaocong Yu;Tshidi Tsibane;Patricia A. McGraw;Frances S. House

  • Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein.

    Seth J. Zost;Pavlo Gilchuk;Rita E. Chen;James Brett Case

  • Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions.

    Ruklanthi De Alwis;Scott A. Smith;Nicholas P. Olivarez;William B. Messer

  • Mxra8 is a receptor for multiple arthritogenic alphaviruses

    Rong Zhang;Arthur S. Kim;Julie M. Fox;Sharmila Nair

  • Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

    Gopal Sapparapu;Estefania Fernandez;Nurgun Kose;Bin Cao

  • Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

    Unknown

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.

    Naveenchandra Suryadevara;Swathi Shrihari;Pavlo Gilchuk;Laura A. VanBlargan

  • Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.

    Emma S. Winkler;Pavlo Gilchuk;Jinsheng Yu;Adam L. Bailey

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans

    Unknown

  • The Role of Human Metapneumovirus in Upper Respiratory Tract Infections in Children: A 20-Year Experience

    John V. Williams;Chiaoyin K. Wang;Chin-Fen Yang;Sharon J. Tollefson

  • High frequency of shared clonotypes in human B cell receptor repertoires

    Cinque Soto;Robin G. Bombardi;Andre Branchizio;Nurgun Kose

  • Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies

    Rodrigo Martino;Rocío Parody Porras;Nuria Rabella;John V. Williams

  • Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools

    Jason A. Greenbaum;Pernille Haste Andersen;Martin Blythe;Huynh-Hoa Bui

  • Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

    Ana Clara Monsalvo;Juan P Batalle;M Florencia Lopez;Jens C Krause

Frequent Co-Authors

Michael S. Diamond
Michael S. Diamond Washington University in St. Louis
Benjamin J. Doranz
Benjamin J. Doranz University of Pennsylvania
John V. Williams
John V. Williams University of Pittsburgh
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center
Jens Meiler
Jens Meiler Vanderbilt University
Andrew B. Ward
Andrew B. Ward Scripps Research Institute
Alexander Bukreyev
Alexander Bukreyev The University of Texas Medical Branch at Galveston
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Aravinda M. de Silva
Aravinda M. de Silva University of North Carolina at Chapel Hill
Ian A. Wilson
Ian A. Wilson Scripps Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, numerous related online degrees can pave the way to fulfilling healthcare careers. Many programs are designed with flexibility in mind, catering to diverse backgrounds and schedules.

Non-nurses seeking to enter the field may find online ABSN programs for non nurses particularly appealing. These programs accelerate the path to becoming registered nurses without requiring prior nursing experience, making them an efficient choice for career changers.

If access is a concern, exploring the easiest ABSN programs to get into can help candidates find schools with more inclusive admission criteria. This approach broadens opportunities for many aspiring healthcare professionals.

Similarly, those interested in practical nursing can benefit from researching LPN schools easy to get into, which provide quicker entry points into the nursing workforce.

For advanced practice roles, easiest nurse practitioner degree programs offer pathways that combine comprehensive training with accessible admissions, preparing graduates for specialized clinical care careers.

Overall, these related online degrees create diverse career pathways that complement Immunology studies, enabling professionals to contribute meaningfully to healthcare and patient outcomes.

Best Scientists Citing James E. Crowe

Trending Scientists

Recently Published Articles